These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 27027431)

  • 1. p21-activated kinase 1 (PAK1) expression correlates with prognosis in solid tumors: A systematic review and meta-analysis.
    Fang F; Pan J; Li YP; Li G; Xu LX; Su GH; Li ZH; Feng X; Wang J
    Oncotarget; 2016 May; 7(19):27422-9. PubMed ID: 27027431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PAK1 overexpression promotes cell proliferation in cutaneous T cell lymphoma via suppression of PUMA and p21.
    Wang Y; Gu X; Li W; Zhang Q; Zhang C
    J Dermatol Sci; 2018 Apr; 90(1):60-67. PubMed ID: 29307600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical association of programmed cell death protein 4 (PDCD4) with solid tumors and its prognostic significance: a meta-analysis.
    Li JZ; Gao W; Ho WK; Lei WB; Wei WI; Chan JY; Wong TS
    Chin J Cancer; 2016 Nov; 35(1):95. PubMed ID: 27852288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between Pak1 expression and subcellular localization and tamoxifen resistance in breast cancer patients.
    Holm C; Rayala S; Jirström K; Stål O; Kumar R; Landberg G
    J Natl Cancer Inst; 2006 May; 98(10):671-80. PubMed ID: 16705121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of NEK2 in human solid tumors: a systematic review and meta-analysis.
    Wang X; Chen K; Liu H; Huang Z; Chen X; Yin L
    Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30578380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of P21-activated kinase 1 and cell division control protein 42 homolog correlates with clinicopathological features and prognosis in cervical carcinoma.
    Feng Y; Fang S; Li M
    J Obstet Gynaecol Res; 2016 Jul; 42(7):860-9. PubMed ID: 27060895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of Aurora kinase A (AURKA) expression among solid tumor patients: a systematic review and meta-analysis.
    Zhang J; Li B; Yang Q; Zhang P; Wang H
    Jpn J Clin Oncol; 2015 Jul; 45(7):629-36. PubMed ID: 25900902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological signature of p21-activated kinase 1 in prostate cancer and its regulation of proliferation and autophagy via the mTOR signaling pathway.
    Wang Z; Jia G; Li Y; Liu J; Luo J; Zhang J; Xu G; Chen G
    Oncotarget; 2017 Apr; 8(14):22563-22580. PubMed ID: 28186966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen receptor-alpha phosphorylation at serine 305, nuclear p21-activated kinase 1 expression, and response to tamoxifen in postmenopausal breast cancer.
    Bostner J; Skoog L; Fornander T; Nordenskjöld B; Stål O
    Clin Cancer Res; 2010 Mar; 16(5):1624-33. PubMed ID: 20179234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Personalizing risk stratification by addition of PAK1 expression to TNM staging: improving the accuracy of clinical decision for gastroesophageal junction adenocarcinoma.
    Li Z; Zou X; Xie L; Chen H; Chen Y; Yeung SC; Zhang H
    Int J Cancer; 2015 Apr; 136(7):1636-45. PubMed ID: 25159681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological significance and the associated signaling pathway of p21-activated kinase 1 (PAK1) in colorectal cancer.
    Pyo JS; Min KW; Oh IH; Lim DH; Son BK
    Pathol Res Pract; 2023 Nov; 251():154820. PubMed ID: 37801909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PKA-induced phosphorylation of ERα at serine 305 and high PAK1 levels is associated with sensitivity to tamoxifen in ER-positive breast cancer.
    Kok M; Zwart W; Holm C; Fles R; Hauptmann M; Van't Veer LJ; Wessels LF; Neefjes J; Stål O; Linn SC; Landberg G; Michalides R
    Breast Cancer Res Treat; 2011 Jan; 125(1):1-12. PubMed ID: 20213082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular pathways: targeting p21-activated kinase 1 signaling in cancer--opportunities, challenges, and limitations.
    Eswaran J; Li DQ; Shah A; Kumar R
    Clin Cancer Res; 2012 Jul; 18(14):3743-9. PubMed ID: 22595609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poor prognosis of nucleophosmin overexpression in solid tumors: a meta-analysis.
    Chen S; He H; Wang Y; Liu L; Liu Y; You H; Dong Y; Lyu J
    BMC Cancer; 2018 Aug; 18(1):838. PubMed ID: 30126359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphorylated Pak1 level in the cytoplasm correlates with shorter survival time in patients with glioblastoma.
    Aoki H; Yokoyama T; Fujiwara K; Tari AM; Sawaya R; Suki D; Hess KR; Aldape KD; Kondo S; Kumar R; Kondo Y
    Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6603-9. PubMed ID: 18006760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of p21-activated kinase 1 expression level in patients with upper urinary tract urothelial carcinoma.
    Kuroda K; Asakuma J; Asano T; Horiguchi A; Isono M; Tsujita Y; Sato A; Seguchi K; Ito K; Asano T
    Jpn J Clin Oncol; 2015 Jan; 45(1):103-10. PubMed ID: 25324479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of microRNA-101 in solid tumor: A meta-analysis.
    Ma X; Bai J; Xie G; Liu Y; Shuai X; Tao K
    PLoS One; 2017; 12(7):e0180173. PubMed ID: 28742860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of p21-activated kinase 1 inhibition on 11q13-amplified ovarian cancer cells.
    Prudnikova TY; Villamar-Cruz O; Rawat SJ; Cai KQ; Chernoff J
    Oncogene; 2016 Apr; 35(17):2178-85. PubMed ID: 26257058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P21-activated kinase 1 and 4 were associated with colorectal cancer metastasis and infiltration.
    Song B; Wang W; Zheng Y; Yang J; Xu Z
    J Surg Res; 2015 Jun; 196(1):130-5. PubMed ID: 25791829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p21-activated protein kinase 1 induces the invasion of gastric cancer cells through c-Jun NH2-terminal kinase-mediated activation of matrix metalloproteinase-2.
    Li LH; Wu GY; Lu YZ; Chen XH; Liu BY; Zheng MH; Cai JC
    Oncol Rep; 2017 Jul; 38(1):193-200. PubMed ID: 28534988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.